For help on how to get the results you want, see our search tips.
8773 results
-
List item
Human medicine European public assessment report (EPAR): Bridion (updated)
sugammadex, Neuromuscular Blockade
Date of authorisation: 25/07/2008, Revision: 15, Authorised -
List item
Human medicine European public assessment report (EPAR): Cystadane (updated)
Betaine anhydrous, Homocystinuria
Date of authorisation: 14/02/2007, Revision: 12, Authorised -
List item
Human medicine European public assessment report (EPAR): Ifirmasta (previously Irbesartan Krka) (updated)
irbesartan hydrochloride, Hypertension
Date of authorisation: 01/12/2008,
, Revision: 10, Authorised
-
List item
Human medicine European public assessment report (EPAR): Lonsurf (updated)
trifluridine, tipiracil hydrochloride, Colorectal Neoplasms
Date of authorisation: 25/04/2016,
, Revision: 3, Authorised
-
List item
Human medicine European public assessment report (EPAR): Lynparza (updated)
Olaparib, Ovarian Neoplasms
Date of authorisation: 16/12/2014,, Revision: 6, Authorised
-
List item
Human medicine European public assessment report (EPAR): Exforge (updated)
amlodipine (as besylate), valsartan, Hypertension
Date of authorisation: 16/01/2007, Revision: 23, Authorised -
List item
Human medicine European public assessment report (EPAR): Fosavance (updated)
alendronic acid, colecalciferol, Osteoporosis, Postmenopausal
Date of authorisation: 24/08/2005, Revision: 21, Authorised -
List item
Human medicine European public assessment report (EPAR): Rubraca (updated)
rucaparib camsylate, Ovarian Neoplasms
Date of authorisation: 23/05/2018,, 
, Revision: 3, Authorised
-
List item
Human medicine European public assessment report (EPAR): Voriconazole Accord (updated)
voriconazole, Aspergillosis, Candidiasis, Mycoses
Date of authorisation: 16/05/2013,, Revision: 11, Authorised
-
List item
Human medicine European public assessment report (EPAR): Cerdelga (updated)
eliglustat, Gaucher Disease
Date of authorisation: 19/01/2015,, 
, Revision: 10, Authorised
-
List item
Human medicine European public assessment report (EPAR): Orgalutran (updated)
ganirelix, Reproductive Techniques, Assisted, Ovulation Induction
Date of authorisation: 16/05/2000, Revision: 19, Authorised -
List item
Human medicine European public assessment report (EPAR): Trelegy Ellipta (updated)
fluticasone furoate, umeclidinium bromide, vilanterol trifenatate, Pulmonary Disease, Chronic Obstructive
Date of authorisation: 15/11/2017,, Revision: 4, Authorised
-
List item
Human medicine European public assessment report (EPAR): Sirturo (updated)
bedaquiline fumarate, Tuberculosis, Multidrug-Resistant
Date of authorisation: 05/03/2014,, , , Revision: 15, Authorised
-
List item
Human medicine European public assessment report (EPAR): Dynastat (updated)
parecoxib sodium, Pain, Postoperative
Date of authorisation: 22/03/2002, Revision: 28, Authorised -
List item
Human medicine European public assessment report (EPAR): Ifirmacombi (updated)
irbesartan, hydrochlorothiazide, Hypertension
Date of authorisation: 04/03/2011,, Revision: 9, Authorised
-
List item
Human medicine European public assessment report (EPAR): Docetaxel Zentiva (previously Docetaxel Winthrop) (updated)
docetaxel, Head and Neck Neoplasms, Carcinoma, Non-Small-Cell Lung, Adenocarcinoma, Prostatic Neoplasms, Stomach Neoplasms, Breast Neoplasms
Date of authorisation: 20/04/2007, Revision: 30, Authorised -
List item
Human medicine European public assessment report (EPAR): Irbesartan Hydrochlorothiazide Zentiva (previously Irbesartan Hydrochlorothiazide Winthrop) (updated)
irbesartan, hydrochlorothiazide, Hypertension
Date of authorisation: 18/01/2007, Revision: 24, Authorised -
List item
Human medicine European public assessment report (EPAR): Nerlynx (updated)
neratinib, Breast Neoplasms
Date of authorisation: 31/08/2018,, Revision: 1, Authorised
-
List item
Human medicine European public assessment report (EPAR): Darunavir Mylan (updated)
darunavir, HIV Infections
Date of authorisation: 03/01/2017,, Revision: 4, Authorised
-
List item
Human medicine European public assessment report (EPAR): Copalia HCT (updated)
amlodipine, valsartan, hydrochlorothiazide, Hypertension
Date of authorisation: 03/11/2009, Revision: 14, Authorised -
List item
Human medicine European public assessment report (EPAR): Aprovel (updated)
irbesartan, Hypertension
Date of authorisation: 26/08/1997, Revision: 38, Authorised -
List item
Human medicine European public assessment report (EPAR): Baraclude (updated)
Entecavir, Hepatitis B, Chronic
Date of authorisation: 26/06/2006, Revision: 24, Authorised -
List item
Human medicine European public assessment report (EPAR): Karvea (updated)
irbesartan, Hypertension
Date of authorisation: 26/08/1997, Revision: 37, Authorised -
List item
Human medicine European public assessment report (EPAR): Irbesartan Zentiva (previously Irbesartan Winthrop) (updated)
irbesartan, Hypertension
Date of authorisation: 19/01/2007, Revision: 21, Authorised -
List item
Human medicine European public assessment report (EPAR): Pemetrexed Sandoz (updated)
pemetrexed disodium hemipentahydrate, Carcinoma, Non-Small-Cell Lung, Mesothelioma
Date of authorisation: 18/09/2015,, Revision: 4, Authorised